• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY CUTTING BALLOON; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY CUTTING BALLOON; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Model Number UNK103
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Vasoconstriction (2126)
Event Date 12/17/2015
Event Type  Injury  
Manufacturer Narrative
Device evaluated by mfr.: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Same case as mdr id #: 2134265-2016-00019; 2134265-2015-09377; 2134265-2016-00294; 2134265-2016-00293.(b)(4).It was reported that myocardial infarction (mi) and in-stent restenosis (isr) occurred.In (b)(6) 2013, the patient was presented with unstable angina and was referred for cardiac catheterization.Subsequently, index procedure were performed.The first target lesion was located in the mid right coronary artery (rca)with 75% stenosis and was 30 mm long with a reference vessel diameter of 3.0 mm.The lesion was treated with direct stent placement using a 3.00mmx38mm promus element plus drug-eluting stent.However, a dissection occurred which was then treated with placement of a 3.00mmx16mm promus element plus drug-eluting stent which overlapped proximally, resulting to 0% residual stenosis.The second target lesion was located in the distal left anterior descending (lad) artery with 75% stenosis and was 15 mm long with a reference vessel diameter of 2.5 mm.The lesion was treated with direct stent placement using a 2.50mmx20mm promus element plus drug-eluting stent.Following post-dilatation resulting to 0% residual stenosis.One day post procedure, the patient was discharged on aspirin and prasugrel.In (b)(6) 2015, the patient experienced unstable angina and target lesion revascularization was performed in the distal lad with promus element 2.5x8mm and a non-bsc stent in (b)(6) 2015, the patient presented with left sided chest pain and was hospitalized on the same day.The patient was then referred for cardiac catheterization.Elevated troponin values were observed and site reported an event of mi.Subsequently, coronary angiography revealed 50% stenosis in the mid lad, 90% in-stent restenosis (isr) of distal study stents and 50% ostial stenosis in second diagonal branch.Three days post-hospitalization, a 182cm choice floppy guidewire was directed down the mid lad by ballooning with a 2.50x20mm maverick balloon catheter and a 2.25x15mm cutting balloon catheter with some diffused spasm of the vessel noted post-treatment which was relieved with an intracoronary nitroglycerin.Subsequently, a 2.5x20mm promus premier drug-eluting was placed and balloon angioplasty was performed in mid lad resulting from 99% to 0% restenosis.Six days later, the patient complained of repeat chest discomfort and was brought back to cath lab.Coronary angiography revealed mild to moderate narrowing from intimal hyperplasia in the distal third of the stent segment.Isr in the distal lad was treated with cutting balloon angioplasty.On the following day, the event was considered resolved and the patient was discharged on aspirin and prasugrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CUTTING BALLOON
Type of Device
CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5366593
MDR Text Key35966405
Report Number2134265-2016-00289
Device Sequence Number1
Product Code LIT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K040155
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 01/11/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK103
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/11/2016
Initial Date FDA Received01/14/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age65 YR
-
-